Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
κ-opioid receptor - Wikipedia
New Kappa-Opioid Receptor Agonist Curbs Pain, Avoids Side Effects
Pharmaceuticals | Free Full-Text | Opioid Analgesia and Opioid-Induced Adverse Effects: A Review
Molecules | Free Full-Text | Biased Opioid Ligands
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Table II from Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review. | Semantic Scholar
A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics - ScienceDirect
Understanding opioids in veterinary medicine
Pharmaceuticals | Free Full-Text | Therapeutic Potential of Kappa Opioid Agonists
Activation of kappa opioid receptor (KOR) signaling increases... | Download Scientific Diagram
6,5-Fused Ring, C2-Salvinorin Ester, Dual Kappa and Mu Opioid Receptor Agonists as Analgesics Devoid of Anxiogenic Effects | Biological and Medicinal Chemistry | ChemRxiv | Cambridge Open Engage
Kappa Opiate Receptor - an overview | ScienceDirect Topics
Frontiers | Traumatic Stress-Induced Vulnerability to Addiction: Critical Role of the Dynorphin/Kappa Opioid Receptor System
Mu Agonist Opioids and Kappa Opioids | Download Table
Kappa Receptors – Opioid Peptides
Opioids in cancer: The κ‑opioid receptor (Review)
A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain | SpringerLink
Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile - British Journal of Anaesthesia
An updated assessment of the translational promise of G-protein-biased kappa opioid receptor agonists to treat pain and other indications without debilitating adverse effects - ScienceDirect
Peripheral Kappa Opioid Receptor Signaling Takes on a Central Role | Semantic Scholar
New Kappa-Opioid Receptor Agonist Curbs Pain, Avoids Side Effects
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
